Veru sheds 13% to end rally as director sells shares
COVID-19 drugmaker Veru (NASDAQ:VERU) snapped a six-day rally Thursday, losing ~13% in the morning hours after one of the company's directors sold over $2.0M worth of VERU stock as part of an option exercise.
According to an SEC filing submitted on Wednesday, VERU director Dr. Mario Eisenberger sold his entire stake of 100K shares in the biopharma company at a weighted average price of $20.04 per share on Monday.